Zhihao Li
ORCID: 0000-0002-1030-3924Also affiliated with Chinese Academy of Sciences, ShanghaiTech University, Beijing National Laboratory for Molecular Sciences, Jilin Medical University, University of Chinese Academy of Sciences, State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, South China University of Technology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable Cholangiocarcinoma”.
Vanja Podrascanin, Zhihao Li, Jonas Santol, Markus Ammann, Lionel A. Kankeu Fonkoua +7 more
Jonas Santol, Vanja Podrascanin, Zhihao Li, Markus Ammann, Lionel A. Kankeu Fonkoua +7 more
Baoshi Yuan, Pancheng Xie, Yue Gu, Zhiwei Liu, Tao Wang +4 more